The allergy drug, dupilumab, is meant to treat underlying causes of asthma, eczema and nasal polyps and could transform treatment of those suspected related ailments, the officials say.
To read more about this article, please follow this link to the NewsMax Health website.
See more eczema-related news headlines on What The Papers Say.
Disclaimer Contact us
©2006 – 2022 NSGCCE and its contributors.
Website: www.nottinghameczema.org.uk
Email: enquiry@nottinghameczema.org.uk
Browser does not support script.